Article (Scientific journals)
Micro Factors Bringing the Pharmaceutical Industry to a Seismic Shaking A Qualitative Research
Dierks, Raphaela Marie Louisa; Bruyère, Olivier; Reginster, Jean-Yves
2017In Expert Review of Pharmacoeconomics and Outcomes Research, 17 (3), p. 267-74
Peer Reviewed verified by ORBi
 

Files


Full Text
Micro factors bringing the pharmaceutical industry to a seismic.pdf
Publisher postprint (1.01 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Business model; Merger & Acquisitions; cross-sectorial collaborations and partnerships; hurdles; innovations; macro and micro changes; stakeholders
Abstract :
[en] INTRODUCTION: Due to changing macro and micro factors, expiring patents and falling net income, pharmaceutical companies need to rethink their vertical business model. The trend shows cross-sectorial partnerships and consolidation to remain and compete on the market. Areas covered: Quantitative research interviewing a target group of 25 key executives from small, mid and large global pharmaceutical companies rounded with qualitative literature research completing the analysis. Expert commentary: Uncertainty in the industry due to changing external factors i.e. pricing pressures, regulations or an economic slowdown, slowing down innovations and new drug outcomes. Pharmaceutical companies understand the existing hurdles, and are critically optimistic implementing new business models. Also, various stakeholders are included in the value chain due to their growing importance. CONCLUSION: During the next years, the industry will be restructured from volume towards value, and only pharmaceutical companies' clairaudient and reciprocate to the changes with an out-off the box thinking will be able to resist on the market. Small biotech companies should focus on research, and big pharmaceutical companies entering at development focusing on the process until the distribution. This execution business recommendation would enable the best know-how at the right point, mitigating the risk and enhancing the patient outcomes.
Disciplines :
Pharmacy, pharmacology & toxicology
Public health, health care sciences & services
Author, co-author :
Dierks, Raphaela Marie Louisa ;  Université de Liège - ULiège > Doct. sc. santé publ. (paysage)
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Micro Factors Bringing the Pharmaceutical Industry to a Seismic Shaking A Qualitative Research
Publication date :
2017
Journal title :
Expert Review of Pharmacoeconomics and Outcomes Research
ISSN :
1473-7167
eISSN :
1744-8379
Publisher :
Taylor & Francis, United Kingdom
Volume :
17
Issue :
3
Pages :
267-74
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 22 September 2017

Statistics


Number of views
59 (9 by ULiège)
Number of downloads
3 (3 by ULiège)

Scopus citations®
 
1
Scopus citations®
without self-citations
1
OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi